| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10071943 | American Journal of Ophthalmology | 2005 | 12 Pages |
Abstract
Fifty-five IU ovine hyaluronidase showed statistically significant efficacy as early as months 1 and 2. These results were supported by outcomes for three key secondary endpoints. These results suggest a therapeutic utility of ovine hyaluronidase in the management of vitreous hemorrhage.
Related Topics
Health Sciences
Medicine and Dentistry
Ophthalmology
Authors
Baruch D. MD, PhD, Edgar L. MD, Marc D. MDCM, PhD, Lisa R. PhD, Vitrase for Vitreous Hemorrhage Study Groups Vitrase for Vitreous Hemorrhage Study Groups,